Cargando…
Mechanistic Studies on the Stereoselectivity of FFAR1 Modulators
[Image: see text] Free fatty acid receptor 1 (FFAR1) is a potential therapeutic target for the treatment of type 2 diabetes (T2D). It has been validated that agonists targeting FFAR1 can achieve the initial therapeutic endpoints of T2D, and the epimer agonists (R,S) AM-8596 can activate FFAR1 differ...
Autores principales: | Teng, Dan, Zhou, Yang, Tang, Yun, Liu, Guixia, Tu, Yaoquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364411/ https://www.ncbi.nlm.nih.gov/pubmed/35877470 http://dx.doi.org/10.1021/acs.jcim.2c00417 |
Ejemplares similares
-
Mechanistic Insights into the Regio‐ and Stereoselectivities of Testosterone and Dihydrotestosterone Hydroxylation Catalyzed by CYP3A4 and CYP19A1
por: Li, Junhao, et al.
Publicado: (2020) -
Optimization
of First-in-Class Dual-Acting FFAR1/FFAR4
Allosteric Modulators with Novel Mode of Action
por: Lückmann, Michael, et al.
Publicado: (2022) -
FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing
por: Ang, Zhiwei, et al.
Publicado: (2018) -
Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
por: Fabisiak, Adam, et al.
Publicado: (2020) -
Computational Insight Into Vitamin K(1) ω-Hydroxylation by Cytochrome P450 4F2
por: Li, Junhao, et al.
Publicado: (2018)